Repository logo
 
Publication

Can potassium perchlorate and sodium iodine influence Iodine-131 uptake in Cholangiocarcinoma?

dc.contributor.authorBrito, A. F.
dc.contributor.authorPuga, T.
dc.contributor.authorTeixo, R.
dc.contributor.authorFernandes, A.
dc.contributor.authorBrito, A. F.
dc.contributor.authorAbrantes, A. M.
dc.contributor.authorMetelo, Luís Francisco
dc.contributor.authorTralhão, J. G.
dc.contributor.authorBotelho, M. F.
dc.date.accessioned2024-11-26T16:07:58Z
dc.date.available2024-11-26T16:07:58Z
dc.date.issued2015-10
dc.description.abstractCholangiocarcinoma (CC) is a malignancy with poor prognostic, high mortality and limited treatment options, reason why the development of novel treatment strategies by exploiting new targets might be considered as consensually relevant. In fact, it was shown that CC expressed the sodium iodine symporter (NIS), which is responsible for iodine uptake by the cells. NIS is also the responsible for the uptake of iodine-131 (131I) in thyroid tumor and benign diseases, enabling the metabolic radiotherapy and opening possibilities of new treatment approaches for CC.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBrito, A. F., Puga, T., Teixo, R., Fernandes, A., Abrantes, A. M., & Metelo, L. F. (2015). Can potassium perchlorate and sodium iodine influence Iodine-131 uptake in Cholangiocarcinoma? EANM’15, 28th Annual EANM Congress of the European Association of Nuclear Medicine 2015, European Journal of Nuclear Medicine and Molecular Imaging, 42 (Suppl 1), S295–S296.pt_PT
dc.identifier.eissn1619-7089
dc.identifier.issn1619-7070
dc.identifier.urihttp://hdl.handle.net/10400.22/26509
dc.language.isoengpt_PT
dc.publisherSpringer Naturept_PT
dc.relation.publisherversionhttps://link.springer.com/journal/259/volumes-and-issues/42-1/supplementpt_PT
dc.subjectPotassium perchloratept_PT
dc.subjectSodium iodinept_PT
dc.subjectCholangiocarcinoma (CC)pt_PT
dc.titleCan potassium perchlorate and sodium iodine influence Iodine-131 uptake in Cholangiocarcinoma?pt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.endPageS296pt_PT
oaire.citation.startPageS295pt_PT
oaire.citation.titleEANM'15, 28th Annual EANM Congress of the European Association of Nuclear Medicine 2015pt_PT
oaire.citation.volumeEuropean Journal of Nuclear Medicine and Molecular Imaging, 42 (Suppl 1)pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
POSTER_Luís Metelo 2.pdf
Size:
3.92 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: